Since its official launch on June 29, 2007, Apple Inc. (Nasdaq: AAPL) has sold well over 180 million iPhones. Hands down, it's the most successful mobile phone ever launched.
But what most investors don't realize is the huge impact the iPhone has had on medicine.
The fact is, more than any other product on the planet, the iPhone is driving a whole new sector called mobile healthcare, or mHealth for short.
With an iPhone in hand, it will redefine how doctors and other health-care pros work with their patients.
But here's the big payoff: mHealth promises to save millions of lives as doctors use it to detect and treat diseases much more quickly than they could with old-school devices.
These radical advances will undoubtedly make lots of early mHealth investors quite rich.
But don't take my word for it....
A trade group known as GSMA says the mobile healthcare sector will reach total sales of $23 billion by 2017.
Of course, phones and tablets that use Google Inc.'s (Nasdaq: GOOG) Android operating system also could play a big role in the sector.
But at this point the iPhone remains the clear leader in this rapidly growing market.
It's So Much More Than a Phone
That's why I'm glad to introduce you to a startup firm that has staked much of its future on the iPhone platform.
To continue reading, please click here...